Press Releases

Latest News

03-17-2009, SCHOTT North America, Inc.

SCHOTT Developing Syringe Production in United States

Announces Expanded Product Line, Production Capacity in the Pennsylvania Plant at INTERPHEX
March 17, 2009 (at INTERPHEX 2009 in New York) — SCHOTT’s Pharmaceutical Packaging business announced an expansion of both its product line and production capacity in the United States today. The company will add the full line of SCHOTT ready-to-fill syringe products to its portfolio of vials and cartridges manufactured at its existing Pharmaceutical Packaging facility in Lebanon, Penn.
The company expects to add 125 new jobs to its Lebanon facility and will begin hiring this year. The expansion into the syringe market represents a $46 million investment in the facility by SCHOTT.
The expansion of both the product line and U.S. production capacity is designed to meet the accelerating demand for syringes in the North American market. Market analysis shows global demand for prefilled syringes will grow at a rate of 8 - 10 percent a year for the next several years. Ready-to-fill syringes answer the growing market demand for speed and ease of use, while minimizing dosage errors.
“Demand for syringes in the United States has grown steadily in recent years and will continue with the increased incidence and detection of chronic diseases,” said Gary Waller, Director North American Sales & Marketing for SCHOTT Pharmaceutical Packaging. “SCHOTT is well positioned to leverage its high-quality global production capabilities for the U.S. market.”
All SCHOTT products and production processes will conform to the U.S. Food and Drug Administration’s current good manufacturing practice standards. The three-shift production schedule incorporates the most advanced techniques, including dimensional camera inspection and clean room final packaging.
SCHOTT Pharmaceutical Packaging
SCHOTT Pharmaceutical Packaging is one of the world’s leading suppliers of parenteral packaging for the pharmaceutical industry. More than 600 production lines in 12 production sites worldwide produce more than 7 billion syringes, vials, ampoules, cartridges and special articles of tubing glass or polymer. Excellent raw materials, state-of-the-art manufacturing, the use of the latest technologies, and continuous research and development enable the introduction of innovative product solutions to meet the high demands of our customers. The back-up possibilities, offered by our production sites situated all over the world, provide flexibility, reliability and security to our partners. Our production sites operate in a GMP environment and our products comply with the international standards USP, EP and JP.
SCHOTT is a technology-driven, international group that sees its core purpose as the lasting improvement of living and working conditions through special materials and high-tech solutions. Its main areas of focus are defense, household appliance industry, pharmaceutical packaging, optics and opto-electronics, information technology, consumer electronics, lighting, automotive engineering and solar energy.
SCHOTT has a presence in close proximity to its customers through highly efficient production and sales companies in all of its major markets. The company has approximately 17,000 employees producing worldwide sales of approximately $3 billion. In North America, SCHOTT’s holding company SCHOTT Corporation and its subsidiary SCHOTT North America, Inc. and their affiliates employ about 2,500 people in 13 production operations with 4 sales offices.
The company’s technological and economic expertise is closely linked with its social and ecological responsibilities.
Press contact
SCHOTT North America, Inc.
555 Taxter Rd
Elmsford, 10523
Phone: 914-831-2200
Fax: 914-831-2201
Further information
Brian Lynch